Enhancement of liver hemangiomas on t1-weighted mr se images by superparamagnetic iron oxide particles

Journal of Computer Assisted Tomography

Volumn 18, Issue 6, 1994, Pages 888-896

  Grangier, Christian ^a   Tourniaire, Jean ^c   Mentha, Gilles ^a   Schiau, Rodica ^a   Howarth, Nigel ^a   Chachuat, Anne ^b   Grossholz, Marianne ^a   Terrier, Francois ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Laboratoire Guerbet   (France)

^c Hopital cardiop neumologique Louis Pradel ^*  (France)

Author keywords

Hemangioma; Liver neoplasms; Magnetic resonance imaging techniques

Indexed keywords

DIAGNOSIS; IMAGE ENHANCEMENT; IRON OXIDES; SUPERPARAMAGNETISM; TUMORS;

'CURRENT; CONTRAST AGENT; HAEMANGIOMA; INTRAVENOUS ADMINISTRATION; IRON OXIDE PARTICLES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING, TECHNIQUE; RELAXIVITY; SUPERPARAMAGNETIC IRON OXIDES; T1-WEIGHTED;

MAGNETIC RESONANCE IMAGING;

IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; MALE; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL PROCESSING;

EID: 0028032591     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/00004728-199411000-00008     Document Type: Article

References (14)

1. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. Am J Roentgenol 1990;155:943-50.
2. Weissleder R, Papisov M. Pharmaceutical iron oxides for MR imaging. Rev Magn Res Med 1992;4:1-20.
3. Rozenman Y, Zou X, Kantor HL. Signal loss induced by superparamagnetic iron oxide particles in NMR spin-echo images: the role of diffusion. Magn Res Med 1990;14:31-9.
4. Majumdar S, Zoghbi SS, Gore JC. The influence of pulse sequence on the relaxation effects of superparamagnetic iron oxide contrast agent. Magn Res Med 1989;10:289-301.
5. Majumdar S, Zoghbi SS, Pope CF, Gore JC. Quantification of MR relaxation effects of iron oxide particles in liver and spleen. Radiology 1988;169:653-5.
6. Chambon C, Clement O, Le Blanche A, Schouman-Claeys E, Frija G. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Res Imag 1993;11:509-19.
7. Small WC, Nelson RC, Bernardino ME. Dual contrast enhancement of both Tl- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide. Magn Res Imag 1993;11:645-54.
8. Quinn SF, Benjamin GG. Hepatic cavernous hemangiomas: simple diagnostic sign with dynamic bolus CT. Radiology 1992;182:545-8.
9. Hahn PF, Stark DD, Weissleder R, Elizondo G, Saini S, Ferrucci JT. Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology 1990;174:361-6.
10. Freeny PC, Marks WR. Hepatic hemangioma: dynamic bolus CT. Am J Roentgenol 1986;147:711-9.
11. Josephson L, Lewis J, Jacobs P, Hahn PF, Stark DD. The effects of iron oxides on proton relaxivity. Magn Res Imag 1988;6:647-53.
12. Wisse E, Doucet D, Van Bassuyt H. A transmission electron microscopic study on the uptake of AMI-25 by sinusoidal cells. In: Wisse E, Knook DL, McCuskey RS, ed. Cells of the hepatic sinusoid, vol 3. Leiden: Kupffer Cell Foundation, 1991:534-9.
13. Yamamoto M, Yoshimatsu S, Baba Y, Yamashita Y, Miyazaki T, Takahashi M. Value of superparamagnetic iron oxide for MR imaging of small hepatomas. Radiology 1993; 189:428.
14. Ginsberg F, Slavin JD, Spencer RP. Hepatic angiosarcoma: mimicking of angioma on three-phase technetium 99m red blood cell scintigraphy. J Nucl Med 1986;27:1861-3.